US Stock MarketDetailed Quotes
RDY Dr. Reddy's Laboratories
- 14.225
- +0.085+0.60%
Trading Dec 2 11:58 ET
11.85BMarket Cap18.79P/E (TTM)
14.350High14.225Low344.40KVolume14.300Open14.140Pre Close4.92MTurnover0.04%Turnover Ratio18.01P/E (Static)833.05MShares16.89252wk High3.28P/B11.19BFloat Cap12.82552wk Low0.10Dividend TTM786.34MShs Float16.892Historical High0.67%Div YieldTTM0.88%Amplitude0.724Historical Low14.291Avg Price1Lot Size
Dr. Reddy's Laboratories Key Stats
Quarterly+Annual
YOY
| (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -48.03%9.32B | -24.48%8.5B | -22.83%45.43B | -41.46%11.52B | -79.63%4.74B | 93.15%17.93B | 69.05%11.25B | 109.46%58.88B | 3,218.55%19.68B | -10.04%23.26B |
| Net income from continuing operations | -9.36%13.42B | -0.75%13.92B | 23.56%55.68B | 36.26%13.07B | 10.57%13.79B | 33.00%14.8B | 18.10%14.03B | 91.22%45.07B | 996.23%9.59B | 76.52%12.47B |
| Operating gains losses | 79.98%-221M | 126.61%161M | -43.60%-1.58B | 60.50%-158M | 250.53%286M | -135.23%-1.1B | 83.40%-605M | 57.46%-1.1B | 14.89%-400M | -30.14%-190M |
| Depreciation and amortization | 4.91%3.98B | 6.75%3.81B | 17.45%14.84B | 16.43%3.71B | 15.26%3.77B | 21.21%3.79B | 17.02%3.57B | 6.87%12.64B | 7.81%3.19B | 9.91%3.27B |
| Deferred tax | 32.72%5.75B | 10.43%4.9B | 5.79%16.19B | -19.57%2.95B | 15.30%4.47B | -13.02%4.33B | 59.70%4.44B | 75.26%15.3B | 127.80%3.66B | 46.56%3.88B |
| Other non cash items | 125.14%92M | -447.62%-146M | -328.63%-567M | 55.00%-54M | -230.34%-189M | -493.55%-366M | -67.69%42M | 3,642.86%248M | -101.40%-120M | 101.69%145M |
| Change In working capital | -398.35%-7.78B | -60.77%-13.14B | -156.93%-20.18B | -142.05%-2.76B | -354.13%-11.86B | 123.12%2.61B | -4.77%-8.17B | 57.54%-7.86B | 144.81%6.57B | -69.27%4.67B |
| -Change in receivables | -146.29%-3.4B | 83.09%-786M | -40.02%-8.05B | -177.11%-1.92B | -561.61%-8.83B | 297.68%7.34B | 27.83%-4.65B | 66.19%-5.75B | 159.98%2.49B | -68.98%1.91B |
| -Change in inventory | -6.51%-5.01B | -36.33%-6.32B | -594.99%-18.45B | -3,124.79%-3.9B | -216.68%-5.2B | -471.70%-4.7B | -115.22%-4.64B | 73.22%-2.65B | 99.15%-121M | -119.21%-1.64B |
| -Change in payables and accrued expense | -32.47%1.58B | 11.47%2.48B | 14,943.48%3.46B | -290.10%-1.5B | -85.88%390M | 228.65%2.34B | 516.48%2.22B | -99.48%23M | -138.59%-384M | 282.14%2.76B |
| -Change in other working capital | 59.35%-963M | -664.69%-8.51B | 441.10%2.86B | -0.72%4.56B | 9.25%1.78B | 66.25%-2.37B | -183.94%-1.11B | -86.85%528M | 72.16%4.59B | -17.65%1.63B |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -48.03%9.32B | -24.48%8.5B | -22.83%45.43B | -41.46%11.52B | -79.63%4.74B | 93.15%17.93B | 69.05%11.25B | 109.46%58.88B | 115.80%19.68B | 34.21%23.26B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -322.21%-19.07B | -145.85%-20.25B | 2.63%-40.28B | 28.04%-11.35B | 38.74%-16.18B | -178.79%-4.52B | -67.30%-8.24B | -56.79%-41.37B | 28.27%-15.77B | -856.54%-26.41B |
| Capital expenditure reported | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 30.73%-3.1B |
| Net PPE purchase and sale | -127.77%-7.33B | -35.64%-4.91B | -36.46%-15.34B | -44.73%-16.35B | 97,987.50%7.85B | -2,354.96%-3.22B | -2,122.35%-3.62B | 21.34%-11.24B | 21.99%-11.3B | -78.38%8M |
| Net intangibles purchase and sale | 119.66%46M | 84.60%-1.31B | -45.98%-11.01B | -46.25%-11.03B | --8.79B | ---234M | ---8.53B | -422.73%-7.54B | -71.86%-7.54B | --0 |
| Net business purchase and sale | ---- | ---- | ---12M | --0 | ---12M | ---- | ---- | --0 | --0 | ---- |
| Net investment purchase and sale | 2,338.67%39.13B | -507.03%-14.47B | 32.79%-15.7B | 54.80%-5.55B | 49.05%-11.96B | -119.68%-1.75B | 1.43%3.56B | -108.61%-23.37B | 31.87%-12.27B | -1,759.36%-23.48B |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -322.21%-19.07B | -145.85%-20.25B | 2.63%-40.28B | 28.04%-11.35B | 38.74%-16.18B | -178.79%-4.52B | -67.30%-8.24B | -56.79%-41.37B | 28.27%-15.77B | -856.54%-26.41B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 329.53%16.15B | 746.41%9.54B | 85.99%-3.76B | 87.60%-533M | 806.00%5.28B | 43.01%-7.04B | 86.33%-1.48B | -1,009.04%-26.86B | -184.32%-4.3B | 122.70%583M |
| Net issuance payments of debt | 2,920.27%16.56B | 1,135.92%10.27B | 121.31%4.35B | 102.64%109M | 431.54%5.82B | 91.70%-587M | 90.37%-991M | -845.78%-20.4B | -176.45%-4.13B | 149.80%1.09B |
| Net common stock issuance | 948.69%7.19B | -75.95%19M | 118.75%805M | -85.97%31M | -88.89%9M | 1,860.00%686M | 154.84%79M | 10.18%368M | 2,662.50%221M | 80.00%81M |
| Cash dividends paid | -0.21%-6.66B | --0 | -33.52%-6.65B | --0 | --0 | -33.52%-6.65B | --0 | -20.09%-4.98B | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 329.53%16.15B | 746.41%9.54B | 85.99%-3.76B | 87.60%-533M | 806.00%5.28B | 43.01%-7.04B | 86.33%-1.48B | -1,009.04%-26.86B | -184.32%-4.3B | 122.70%583M |
| Net cash flow | ||||||||||
| Beginning cash position | -32.03%4.91B | 22.98%7.11B | -61.09%5.78B | 20.39%7.54B | 48.85%13.54B | 14.78%7.23B | -61.09%5.78B | 0.22%14.85B | -71.52%6.26B | -8.89%9.09B |
| Current changes in cash | 0.35%6.4B | -243.76%-2.21B | 114.82%1.39B | 7.40%-363M | -140.01%-6.16B | 138.87%6.37B | 116.96%1.54B | -1,235.09%-9.36B | 94.96%-392M | -121.39%-2.57B |
| Effect of exchange rate changes | 65.15%-23M | 119.10%17M | -120.63%-59M | 26.14%-65M | 160.30%161M | -151.56%-66M | -117.35%-89M | -60.98%286M | -113.58%-88M | -4,350.00%-267M |
| End cash Position | -16.62%11.29B | -32.03%4.91B | 22.98%7.11B | 22.98%7.11B | 20.39%7.54B | 48.85%13.54B | 14.78%7.23B | -61.09%5.78B | -61.09%5.78B | -71.52%6.26B |
| Free cash flow | -89.94%1.41B | 324.97%2.07B | -55.02%18B | -67.13%5.24B | -101.51%-305M | 135.00%13.99B | 54.74%-921M | 341.65%40.01B | 212.86%15.93B | 56.81%20.16B |
| Currency Unit | INR | INR | INR | INR | INR | INR | INR | INR | INR | INR |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
